- Home
- ACTG vs NMRA Comparison
ACTG vs NMRA Comparison
Compare ACTG & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- NMRA
- Stock Information
- Founded
- ACTG 1993
- NMRA 2019
- Country
- ACTG United States
- NMRA United States
- Employees
- ACTG N/A
- NMRA N/A
- Industry
- ACTG Multi-Sector Companies
- NMRA
- Sector
- ACTG Miscellaneous
- NMRA
- Exchange
- ACTG Nasdaq
- NMRA Nasdaq
- Market Cap
- ACTG 314.4M
- NMRA 268.5M
- IPO Year
- ACTG 1996
- NMRA 2023
- Fundamental
- Price
- ACTG $3.29
- NMRA $1.62
- Analyst Decision
- ACTG
- NMRA Buy
- Analyst Count
- ACTG 0
- NMRA 8
- Target Price
- ACTG N/A
- NMRA $7.14
- AVG Volume (30 Days)
- ACTG 183.8K
- NMRA 383.3K
- Earning Date
- ACTG 11-11-2025
- NMRA 11-11-2025
- Dividend Yield
- ACTG N/A
- NMRA N/A
- EPS Growth
- ACTG N/A
- NMRA N/A
- EPS
- ACTG N/A
- NMRA N/A
- Revenue
- ACTG $247,813,000.00
- NMRA N/A
- Revenue This Year
- ACTG $109.86
- NMRA N/A
- Revenue Next Year
- ACTG N/A
- NMRA N/A
- P/E Ratio
- ACTG N/A
- NMRA N/A
- Revenue Growth
- ACTG 62.44
- NMRA N/A
- 52 Week Low
- ACTG $2.70
- NMRA $0.61
- 52 Week High
- ACTG $5.36
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- ACTG 47.36
- NMRA 47.71
- Support Level
- ACTG $3.13
- NMRA $1.60
- Resistance Level
- ACTG $3.40
- NMRA $1.70
- Average True Range (ATR)
- ACTG 0.12
- NMRA 0.09
- MACD
- ACTG 0.01
- NMRA -0.01
- Stochastic Oscillator
- ACTG 42.11
- NMRA 8.51
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.